490 related articles for article (PubMed ID: 34803712)
1. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity.
Fu K; Wang C; Ma C; Zhou H; Li Y
Front Pharmacol; 2021; 12():771459. PubMed ID: 34803712
[TBL] [Abstract][Full Text] [Related]
2. The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity.
Chen J; Xu J; Huang P; Luo Y; Shi Y; Ma P
Biomed Pharmacother; 2022 May; 149():112866. PubMed ID: 35367767
[TBL] [Abstract][Full Text] [Related]
3. Forsythiae Fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways.
Hu N; Guo C; Dai X; Wang C; Gong L; Yu L; Peng C; Li Y
J Ethnopharmacol; 2020 Nov; 262():113275. PubMed ID: 32810620
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages.
Harikrishnan H; Jantan I; Haque MA; Kumolosasi E
BMC Complement Altern Med; 2018 Jul; 18(1):224. PubMed ID: 30045725
[TBL] [Abstract][Full Text] [Related]
5. Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety.
Jia Q; Zhu R; Tian Y; Chen B; Li R; Li L; Wang L; Che Y; Zhao D; Mo F; Gao S; Zhang D
Phytomedicine; 2019 May; 58():152871. PubMed ID: 30851580
[TBL] [Abstract][Full Text] [Related]
6. p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats.
Yang Q; Xu Y; Feng G; Hu C; Zhang Y; Cheng S; Wang Y; Gong X
Afr J Tradit Complement Altern Med; 2014; 11(1):213-21. PubMed ID: 24653580
[TBL] [Abstract][Full Text] [Related]
7. 2,3,5,4'-tetrahydroxystilbence-2-O-β-D-glucoside attenuates hepatic steatosis via IKKβ/NF-κB and Keap1-Nrf2 pathways in larval zebrafish.
Wang C; Hu NH; Yu LY; Gong LH; Dai XY; Peng C; Li YX
Biomed Pharmacother; 2020 Jul; 127():110138. PubMed ID: 32387861
[TBL] [Abstract][Full Text] [Related]
8. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice.
Feng Z; Pang L; Chen S; Pang X; Huang Y; Qiao Q; Wang Y; Vonglorkham S; Huang Q; Lin X; Wei J
Int Immunopharmacol; 2020 Nov; 88():107003. PubMed ID: 33182043
[TBL] [Abstract][Full Text] [Related]
9. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease.
Zhou H; Ma C; Wang C; Gong L; Zhang Y; Li Y
Eur J Pharmacol; 2021 May; 898():173976. PubMed ID: 33639194
[TBL] [Abstract][Full Text] [Related]
10. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
11. Zerumbone suppresses the activation of inflammatory mediators in LPS-stimulated U937 macrophages through MyD88-dependent NF-κB/MAPK/PI3K-Akt signaling pathways.
Haque MA; Jantan I; Harikrishnan H
Int Immunopharmacol; 2018 Feb; 55():312-322. PubMed ID: 29310107
[TBL] [Abstract][Full Text] [Related]
12. Standardized extract of Zingiber zerumbet suppresses LPS-induced pro-inflammatory responses through NF-κB, MAPK and PI3K-Akt signaling pathways in U937 macrophages.
Haque MA; Jantan I; Harikrishnan H; Ghazalee S
Phytomedicine; 2019 Feb; 54():195-205. PubMed ID: 30668369
[TBL] [Abstract][Full Text] [Related]
13. Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder.
Zhao XJ; Yang YZ; Zheng YJ; Wang SC; Gu HM; Pan Y; Wang SJ; Xu HJ; Kong LD
Eur J Pharmacol; 2017 Aug; 809():141-150. PubMed ID: 28526339
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
15. [Nrf2-NF-κB pathway axes, epigenetic regulation and traditional Chinese medicine (natural medicine) to treat type 2 diabetes].
Zhai CM; Jia BY; Wang ZB; Huai X; Ma ZC; Tian ZK; Meng YH
Zhongguo Zhong Yao Za Zhi; 2016 Dec; 41(23):4314-4319. PubMed ID: 28933105
[TBL] [Abstract][Full Text] [Related]
16. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
[TBL] [Abstract][Full Text] [Related]
17. Gold-quercetin nanoparticles prevent metabolic endotoxemia-induced kidney injury by regulating TLR4/NF-κB signaling and Nrf2 pathway in high fat diet fed mice.
Xu MX; Wang M; Yang WW
Int J Nanomedicine; 2017; 12():327-345. PubMed ID: 28115850
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives.
Wang C; Wu R; Zhang S; Gong L; Fu K; Yao C; Peng C; Li Y
Biomed Pharmacother; 2023 Oct; 166():115410. PubMed ID: 37659207
[TBL] [Abstract][Full Text] [Related]
19. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
Wang L; Jia Z; Wang B; Zhang B
Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
[TBL] [Abstract][Full Text] [Related]
20. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
Lu L; Wu C; Lu BJ; Xie D; Wang Z; Bahaji Azami NL; An YT; Wang HJ; Ye G; Sun MY
J Ethnopharmacol; 2020 Mar; 249():112301. PubMed ID: 31622746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
